Regulation of B7-H1 expression on peripheral monocytes and IFN-γ secretion in T lymphocytes by HBeAg

Cellular Immunology

Volumn 283, Issue 1-2, 2013, Pages 25-30

  Han, Yaping ^a   Li, Jun ^a   Jiang, Longfeng ^a   Xu, Qingqing ^a   Liu, Bo ^a   Jin, Ke ^a   Liu, Yuan ^a   Huang, Zuhu ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

B7 H1; Hepatitis B virus E antigen; Innate immunity; Monocyte; PD 1; Regulate; Toll like receptors 2

Indexed keywords

CD14 ANTIGEN; CD3 ANTIGEN; GAMMA INTERFERON; HEPATITIS B(E) ANTIGEN; PROGRAMMED DEATH 1 LIGAND 1; TOLL LIKE RECEPTOR 2;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; FEMALE; HEPATITIS B; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

B7-H1; HEPATITIS B VIRUS E ANTIGEN; INNATE IMMUNITY; MONOCYTE; PD-1; REGULATE; TOLL-LIKE RECEPTORS 2;

ADOLESCENT; ADULT; ANTIGENS, CD274; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; IMMUNE TOLERANCE; INTERFERON-GAMMA; MALE; MIDDLE AGED; MONOCYTES; YOUNG ADULT;

EID: 84880337413     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.05.009     Document Type: Article

References (44)

1. Lu F.M., Zhuang H. Management of hepatitis B in China. Chin. Med. J. 2009, 122:3-4.
2. Ganem D., Prince A.M. Hepatitis B virus infection-natural history and clinical consequences. N. Engl. J. Med. 2004, 350:1118-1129.
3. Lee W.M. Hepatitis B virus infection. N. Engl. J. Med. 1997, 337:1733-1745.
4. Milich D., Liang T.J. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 2003, 38:1075-1086.
5. Arakawa K., Tsuda F., Takahashi K., et al. Maternofetal transmission of IgG-bound hepatitis B e antigen. Pediatr. Res. 1982, 16:247-250.
6. Barth H., Klein R., Berg P.A., et al. Induction of T helper cell type 1 response and elimination of HBeAg during treatment with IL-2 in a patient with therapy-refractory chronic hepatitis B. Hepatogastroenterology 2001, 48:553-555.
7. Han Y.P., Li J., Wan Y.F., et al. The influence of hepatitis B e antigen on the expression of toll-like receptor 2 on peripheral monocytes. Chin. J. Hepatol. 2008, 16:739-742.
8. Visvanathan K., Skinher N.A., Thompson A.J., et al. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 2007, 45:102-110.
9. Lok A.S., McMahon B.J. Chronic hepatitis B: update. Hepatology 2009, 50(2009):661-662.
10. Cai J., Guo R.H., Zhou H.Y., et al. Construction and in vitro expression of eukaryotic expression plasmids of HBV middle envelope protein and HBV E antigen. Nanjing Yike Daxue Xuebao 2000, 20:258-262.
11. Han Y.P., Li J., Liu Y., et al. Optimization of dendritic cells in vitro culture conditions. Chin. J. Lab. Med. 2005, 28:852-854.
12. Klausner R.D., Donaldson J.G., Lippincott-Schwartz J. Brefeldin A: insights into the control of membrane traffic and organelle structure. J. Cell Biol. 1992, 116:1071-1080.
13. Suri D., Schilling R., Lopes A.R., et al. Non-cytolytic inhibition of hepatitis B virus replication in human hepatocytes. J. Hepatol. 2001, 35:790-797.
14. Jung M.C., Pape G.R. Immunology of hepatitis B infection. Lancet Infect. Dis. 2002, 2:43-50.
15. Margaret C., Matti S., Janice H., et al. Immune tolerance split between hepatitis B virus precore and core proteins. J. Virol. 2005, 79:3016-3027.
16. Calvin Q.P., Zhang J.X. Natural history and clinical consequences of hepatitis B virus infection. Int. J. Med. Sci. 2005, 2:36-40.
17. Chang C., Enders G., Sprengel R., et al. Expression of the precore region of an avian hepatitis B virus is not required for viral replication. J. Virol. 1987, 61:3322-3325.
18. Chen H.S., Kew M.C., Hornbuckle W.E., et al. The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host. J. Virol. 1992, 66:5682-5684.
19. Schlicht H.J., Salfeld J., Schaller H. The duck hepatitis B virus pre-C region encodes a signal sequence which is essential for synthesis and secretion of processed core proteins but not for virus formation. J. Virol. 1987, 61:3701-3709.
20. Milich D.R. Influence of T-helper cell subsets and crossregulation in hepatitis B virus infection. J. Viral Hepat. 1997, 4:48-59.
21. Milich D.R., Chen M.K., Hughes J.L., et al. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. J. Immunol. 1998, 160:2013-2021.
22. Milich D.R., Jones J., Hughes J., et al. Role of T cell tolerance in the persistence of hepatitis B virus infection. J. Immunother. Emphasis Tumor Immunol. 1993, 14:226-233.
23. Yang C.Y., Kuo T.H., Ting L.P. Human hepatitis B viral e antigen interacts with cellular interleukin-1 receptor accessory protein and triggers interleukin-1 response. J. Biol. Chem. 2006, 281:34525-34536.
24. Woltman A.M., Op den Brouw M.L., Biesta P.J., et al. Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function. PLoS ONE 2011, 6:e15324.
25. Milich D.R., McLachlan A. The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science 1986, 234:1398-1401.
26. Milich D.R., Schödel F., Hughes J.L., et al. The hepatitis B virus core and e antigen elicit different Th cell subsets: antigen structure can affect Th cell phenotype. J. Virol. 1997, 71:2192-2201.
27. Milich D.R., Jones J.E., Hughes J.L., et al. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?. Proc. Natl. Acad. Sci. USA 1990, 87:6599-6603.
28. Webster G.J., Reignat S., Brown D., et al. Longitudinal analysis of CD'8 T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J. Virol. 2004, 78:5707-5719.
29. Han Y.P., Li J., Wan Y.F., et al. Application of HBV histocompatibility complex-peptide pentamer in detection of specific cytotoxic T lymphocytes. Chin. J. Lab. Med. 2009, 32:763-767.
30. Li J., Han Y., Jin K., et al. Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infection. Virol. J. 2011, 8:199.
31. Watanabe T., Bertoletti A., Tanoto T.A. PD-1/PD-L1 pathway and T-cell exhaustion in chronic hepatitis virus infection. J. Viral Hepat. 2010, 17:453-458.
32. Okazakit T., Wang J. PD-1/PD-L pathway and autoimmunity. Autoimmunity 2005, 38:353-357.
33. Freeman G.J., Long A.J., Iwai Y., et al. Engagement of the PD-1 immunoinhibitor receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 2000, 192:1027-1034.
34. Fisicaro P., Valdatta C., Massari M., et al. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology 2010, 138:682-693.
35. Tülek N., Saglam S.K., Saglam M., et al. Soluble interleukin-2 receptor and interleukin-10 levels in patients with chronic hepatitis B infection. Hepatogastroenterology 2000, 47:828-831.
36. Chen J., Wang X.M., Wu X.J., et al. Intrahepatic levels of PD-1/PD-L correlate with liver inflammation in chronic hepatitis B. Inflamm. Res. 2011, 60:47-53.
37. Seo S.K., Seo H.M., Jeong H.Y., et al. Co-inhibitory role of T-cell associated B7-H1 and B7-DC in the T-cell immune response. Immunol. Lett. 2006, 102:222-228.
38. Geng L., Jiang G., Fang Y., et al. B7-H1 expression is upregulated in peripheral blood CD14+ monocytes of patients with chronic hepatitis B virus infection, which correlates with higher serum IL-10 levels. J. Viral Hepat. 2006, 13:725-733.
39. Brooks D.G., Trifilo M.J., Edelmann K.H., et al. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 2006, 12:1301-1309.
40. Diehl S., Rincón M. The two faces of IL-6 on Th1/Th2 differentiation. Mol. Immunol. 2002, 39:531-536.
41. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat. Immunol. 2010, 11:373-384.
42. Texereau J., Chiche J.D., Taylor W., et al. The importance of toll-like receptor 2 polymorphisms in severe infections. Clin. Infect. Dis. 2005, 41:S408-415.
43. Riordan S.M., Skinner N., Kurtovic J., et al. Reduced expression of toll-like receptor 2 on peripheral monocytes in patient is with chronic hepatitis B. Clin. Vaccine Immunol. 2006, 13:972-974.
44. Wu J., Meng Z., Jiang M., et al. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology 2009, 49:1132-1140.